EastEnders’ Lola Pearce and her family vowed to make sure they have an unforgettable family Christmas as it could be their last together in emotional scenes broadcast last night.
It is the latest development in the BBC soap’s brain tumour storyline which has seen the popular character, played by Danielle Harold, diagnosed with a glioblastoma (GBM).
The scenes were poignant for many in the brain tumour community, including Adam Dilley, who is looking forward to Christmas with his loved ones after receiving good news following his latest scan.
Adam was just weeks away from becoming a dad when he was given the devastating news that he had a GBM in October last year. He underwent a craniotomy and then had several weeks of radiotherapy followed by months of chemotherapy.
Adam and his partner Tasha celebrated the much-anticipated arrival of their son, Alfie, last December.
Now, having celebrated his son’s first birthday and spent days anxiously awaiting the results of his latest MRI, Adam has received some good news. His tumour remains stable and he can look forward to enjoying a fun Christmas with his family.
Adam said: “I’m so pleased with my latest scan results and am really looking forward to Christmas.
“It was my boy’s first Christmas last year but I’d literally just had surgery so was a bit beaten up. He’s more grown-up now so it feels like this year is going to be a proper Christmas for him, and I feel great. I haven’t had a headache since the surgery and am back at work full time, so feeling a lot more positive and upbeat.”
(Pictured left to right: Adam’s brother and sister-in-law, Graeme and Fran Dilley, with their children Luca and Emilia, Tasha White and Adam Dilley with their son Alfie and Adam’s parents, Mark and Wendy Dilley)
Related reading:
- Adam’s story
- Dad-to-be’s brain surgery filmed for BBC documentary
- We’ve been diagnosed with the same brain tumour as EastEnders’ Lola
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.